One year prospective survey of Candida bloodstream infections in Scotland
Open accessThe DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Abstract
A 12 month survey of candidaemia in Scotland, UK, in which every Scottish hospital laboratory submitted all blood isolates of yeasts for identification, strain typing and susceptibility testing, provided 300 isolates from 242 patients, generating incidence data of 4.8 cases per 100 000 population per year and 5.9 cases per 100 000 acute occupied bed days; 27.9 % of cases occurred in intensive care units. More than half the patients with candidaemia had an underlying disease involving the abdomen, 78 % had an indwelling intravenous catheter, 62 % had suffered a bacterial infection within the 2 weeks prior to candidaemia and 37 % had undergone a laparotomy.Candida albicans was the infecting species in 50 % of cases, followed by Candida glabrata(21 %) and Candida parapsilosis(12 %). Seven cases of candidaemia were caused by Candida dubliniensis, which was more prevalent even than Candida lusitaniae and Candida tropicalis(six cases each). Among C. glabrata isolates, 55 % showed reduced susceptibility to fluconazole, but azole resistance among other species was extremely low. Multilocus sequence typing showed isolates with high similarity came from different hospitals across the country, and many different types came from the hospitals that submitted the most isolates, indicating no tendency towards hospital-specific endemic strains. Multiple isolates of C. albicans and C. glabrata from individual patients were of the same strain type with single exceptions for each species. The high prevalence of candidaemia in Scotland, relative to other population-based European studies, and the high level of reduced fluconazole susceptibility of Scottish C. glabrata isolates warrant continued future surveillance of invasive Candida infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Scotland had a rate of candidaemia of 4.8 cases per 100,000 population per year shortly after the millennium, 254 bloodstream and 669 invasive Candida cases annually [27].”
From Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision (2017) · cites this paper as [27]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Feil, E. J., Li, B. C., Aanensen, D. M., Hanage, W. P., & Spratt, B. G. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.5.1518-1530.2004 · Cited by 1,861 · cited 2×
“Relatedness of C. albicans isolates that differed from each other in only one of the seven MLST gene loci was determined by eBURST analysis (Feil et al., 2004) and isolates found to be related by this analysis were referred to as clonal clusters.”
MethodGuidelines for Treatment of Candidiasis
Pappas, P. G., Rex, J. H., Sobel, J. D., Filler, S. G., Dismukes, W. E., Walsh, T. J., & Edwards, J. E. (2004) · Clinical Infectious Diseases · doi:10.1086/380796 · Cited by 1,440 · cited 1×
“The most recent recommendations for treatment of candidaemia include removal of IV catheters (this was done in 77 % of our catheterized patients) as well as systemic antifungal therapy (Pappas et al., 2004).”
BackgroundReference method for broth dilution antifungal susceptibility testing of yeasts : Approved standard
Rex, J. H., & Clinical (2008) · Clinical and Laboratory Standards Institute eBooks · Cited by 1,052
Blumberg, H. M., Jarvis, W. R., Soucie, J. M., Edwards, J. E., Patterson, J. E., Pfaller, M. A., Rangel‐Frausto, M. S., Rinaldi, M. G., Saiman, L., Wiblin, R. T., et al. (2001) · Clinical Infectious Diseases · doi:10.1086/321811 · Cited by 661 · cited 2×
“98 described by Blumberg et al. (2001). The differences in cases per occupied ICU bed day may be explained by differences in illness severity.”
BackgroundResultInfluentialTrick, W. E., Fridkin, S. K., Edwards, J. R., Hajjeh, R. A., Gaynes, R. P., & Hospitals, T. N. N. I. S. S. (2002) · Clinical Infectious Diseases · doi:10.1086/342300 · Cited by 660
Trends in Mortality Due to Invasive Mycotic Diseases in the United States, 1980–1997
McNeil, M. M., Nash, S. L., Hajjeh, R. A., Phelan, M. A., Conn, L. A., Plikaytis, B. D., & Warnock, D. W. (2001) · Clinical Infectious Diseases · doi:10.1086/322606 · Cited by 657
Hajjeh, R. A., Sofair, A. N., Harrison, L. H., Lyon, G. M., Arthington-Skaggs, B. A., Mirza, S. A., Phelan, M., Morgan, J., Lee-Yang, W., Ciblak, M. A., et al. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.4.1519-1527.2004 · Cited by 649 · cited 11×
“…in incidence, with an estimated 6 cases per 105 population in Iowa (Diekema et al., 2002), 7 cases per 105 population in Connecticut (Hajjeh et al., 2004), 8 cases per 105 population in Atlanta and San Francisco (Kao et al., 1999), and 24 cases per 105 population in Baltimore…”
BackgroundInfluentialOdds, F. C., & Bernaerts, R. (1994) · Journal of Clinical Microbiology · doi:10.1128/jcm.32.8.1923-1929.1994 · Cited by 629 · cited 2×
“The isolates received were streaked to single colonies on CHROMagar Candida plates to facilitate detection of mixed cultures, and provide presumptive identification of C. albicans/Candida dubliniensis, C. krusei and C. tropicalis (Odds & Bernaerts, 1994).”
BackgroundSelf-citationTavanti, A., Davidson, A. D., Gow, N. A. R., Maiden, M. C. J., & Odds, F. C. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.1.284-292.2005 · Cited by 593 · cited 6×
“Isolates of C. albicans, C. glabrata and C. tropicalis were further characterized by MLST (Bougnoux et al., 2003; Dodgson et al., 2003; Tavanti et al., 2005c).”
BackgroundMethodInfluentialSelf-citationAlmirante, B., Rodríguez, D., Park, B. J., Cuenca-Estrella, M., Planes, A. M., Almela, M., Mensa, J., Sanchez, F., Ayats, J., Gimenez, M., et al. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.4.1829-1835.2005 · Cited by 566 · cited 1×
“Recent surveys of candidaemia from Spain and Italy have shown prevalences of C. parapsilosis between 20 and 40 % (Almirante et al., 2005; Cuenca-Estrella et al., 2002a; Marco et al., 2003; Pemán et al., 2005; San Miguel et al., 2005).”
BackgroundTortorano, A. M., Peman, J., Bernhardt, H., Klingspor, L., Kibbler, C. C., Faure, O., Biraghi, E., Canton, E., Zimmermann, K., Seaton, S., et al. (2004) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-004-1103-y · Cited by 509 · cited 1×
“However, it has been regularly reported as a cause of candidaemia since 1999 (Chan-Tack, 2005; Kibbler et al., 2003; Meis et al., 1999; Tortorano et al., 2004) and one study even identified C. dubliniensis in over 16 % of cases of candidaemia (Fotedar & Al Hedaithy, 2003).”
BackgroundEpidemiology of Candidemia in Swiss Tertiary Care Hospitals: Secular Trends, 1991–2000
Marchetti, O., Bille, J., Fluckiger, U., Eggimann, P., Ruef, C., Garbino, J., Calandra, T., Glauser, M., Tauber, M. G., Pittet, D., et al. (2004) · Clinical Infectious Diseases · doi:10.1086/380637 · Cited by 478
Kao, A. S., Brandt, M. E., Pruitt, W. R., Conn, L. A., Perkins, B. A., Stephens, D. S., Baughman, W. S., Reingold, A. L., Rothrock, G. A., Pfaller, M. A., et al. (1999) · Clinical Infectious Diseases · doi:10.1086/313450 · Cited by 457 · cited 8×
“, 2004), 8 cases per 10(5) population in Atlanta and San Francisco (Kao et al., 1999), and 24 cases per 10(5) population in Baltimore (Hajjeh et al.”
BackgroundInfluentialRangel‐Frausto, M. S., Wiblin, T., Blumberg, H. M., Saiman, L., Patterson, J., Rinaldi, M., Pfaller, M., Edwards, Jr., Jarvis, W., Dawson, J., et al. (1999) · Clinical Infectious Diseases · doi:10.1086/520194 · Cited by 430
Rippon, J. W. (1989) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1989.03430190139055 · Cited by 396
Diekema, D. J., Messer, S. A., Brueggemann, A. B., Coffman, S. L., Doern, G. V., Herwaldt, L. A., & Pfaller, M. A. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.4.1298-1302.2002 · Cited by 385 · cited 4×
“…5) are similar to those of other studies published in recent years, and confirm low or negligible levels of antifungal resistance among C. albicans and C. parapsilosis isolates but a high level of reduced azole susceptibility among C. glabrata isolates (Diekema et al., 2002; Pfaller et al., 2002).”
BackgroundResultInfluentialEpidemiological trends in nosocomial candidemia in intensive care
Bassetti, M., Righi, E., Costa, A., Fasce, R., Molinari, M. P., Rosso, R., Pallavicini, F. B., & Viscoli, C. (2006) · BMC Infectious Diseases · doi:10.1186/1471-2334-6-21 · Cited by 332
Pfaller, M. A., Diekema, D. J., Jones, R. N., Messer, S. A., & Hollis, R. J. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.3.852-856.2002 · Cited by 331 · cited 1×
“…5) are similar to those of other studies published in recent years, and confirm low or negligible levels of antifungal resistance among C. albicans and C. parapsilosis isolates but a high level of reduced azole susceptibility among C. glabrata isolates (Diekema et al., 2002; Pfaller et al., 2002).”
ResultMolecular Phylogenetics of Candida albicans
Odds, F. C., Bougnoux, M.-E., Shaw, D. J., Bain, J. M., Davidson, A. D., Diogo, D., Jacobsen, M. D., Lecomte, M., Li, S.-Y., Tavanti, A., et al. (2007) · Eukaryotic Cell · doi:10.1128/ec.00041-07 · Cited by 307 · cited 7×
“albicans clade 2 was the most common type found among isolates from the UK, followed by clade 4 (Tavanti et al., 2005b; Odds et al., 2007).”
BackgroundMethodInfluentialSelf-citationPfaller, M. A., Diekema, D. J., & Sheehan, D. J. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.19.2.435-447.2006 · Cited by 295 · cited 2×
“…(Trick et al., 2002) and an antifungal surveillance programme involving more than 13 000 bloodstream isolates of Candida species from 1992 to 2004 continues to show C. krusei as the most fluconazole-resistant Candida species, yet it accounts for only 2.3 % of all isolates (Pfaller et al., 2006).”
BackgroundResultInfluentialFungal Flora of the Normal Human Small and Large Intestine
Cohen, R., Roth, F. J., Delgado, E., Ahearn, D. G., & Kalser, M. H. (1969) · New England Journal of Medicine · doi:10.1056/nejm196903202801204 · Cited by 234 · cited 1×
“They found the highest prevalence of positive aspirates in the lower portion of the tract, reaching 60 % in ileal aspirates and 70 % in the colon (Cohen et al., 1969).”
BackgroundPrice, M. F., LaRocco, M. T., & Gentry, L. O. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.6.1422 · Cited by 229 · cited 1×
“The four main C. albicans strain clades described from all sources in previous studies (Blignaut et al., 2002; Odds et al., 2006; Pujol et al., 2002; Soll & Pujol, 2003) remain the most commonly encountered in candidaemia in our study, and these and others were found across the range of hospitals…”
BackgroundCandida Sepsis: Pathogenesis and Principles of Treatment
STONE, H. H., KOLB, L. D., CURRIE, C. A., GEHEBER, C. E., & CUZZELL, J. Z. (1974) · Annals of Surgery · doi:10.1097/00000658-197405000-00024 · Cited by 226 · cited 2×
“In surgical patients at operation in a 1974 study, 47% of patients carried a Candida sp. in the ileum and 65% in the colon ( Stone et al., 1974 ).”
BackgroundEmergence of Candida parapsilosis as the Predominant Species Causing Candidemia in Children
Levy, I., Rubin, L. G., Vasishtha, S., Tucci, V., & Sood, S. K. (1998) · Clinical Infectious Diseases · doi:10.1086/520277 · Cited by 210
Collaborative Consensus for Optimized Multilocus Sequence Typing of Candida albicans
Bougnoux, M.-E., Tavanti, A., Bouchier, C., Gow, N. A. R., Magnier, A., Davidson, A. D., Maiden, M. C. J., d'Enfert, C., & Odds, F. C. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.11.5265-5266.2003 · Cited by 210
Self-citationMcCullough, M. J., Clemons, K. V., & Stevens, D. A. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.2.417-421.1999 · Cited by 203 · cited 2×
“C. albicans was differentiated from C. dubliniensis by PCR determining the position of the ITS1 intron (McCullough et al., 1999).”
BackgroundAndes, D., & van Ogtrop, M. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.9.2116 · Cited by 192 · cited 1×
“C. glabrata isolates remain generally susceptible to amphotericin B, flucytosine and caspofungin (Table 5). When an isolate is found to be in the S-DD category, fluconazole dosing should be increased in an effort to achieve the AUC (area under the curve)/MIC ratio of 25 shown to be needed for eradication of infection…”
BackgroundMultilocus Sequence Typing of Candidaglabrata Reveals Geographically EnrichedClades
Dodgson, A. R., Pujol, C., Denning, D. W., Soll, D. R., & Fox, A. J. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.12.5709-5717.2003 · Cited by 190
Increasing Incidence of Candidemia: Results from a 20-Year Nationwide Study in Iceland
Ásmundsdóttir, L. R., Erlendsdóttir, H., & Gottfredsson, M. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.9.3489-3492.2002 · Cited by 188
Management and outcome of bloodstream infections due to Candida species in England and Wales
Kibbler, C. C., Seaton, S., Barnes, R. A., Gransden, W. R., Holliman, R. E., Johnson, E. M., Perry, J. D., Sullivan, D. J., & Wilson, J. A. (2003) · Journal of Hospital Infection · doi:10.1016/s0195-6701(03)00085-9 · Cited by 187
Sandven, P. (2000) · PubMed · Cited by 185
Tavanti, A., Davidson, A. D., Fordyce, M. J., Gow, N. A. R., Maiden, M. C. J., & Odds, F. C. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.11.5601-5613.2005 · Cited by 178 · cited 6×
“Isolates of C. albicans, C. glabrata and C. tropicalis were further characterized by MLST (Bougnoux et al., 2003; Dodgson et al., 2003; Tavanti et al., 2005c).”
BackgroundMethodInfluentialSelf-citationArendrup, M. C., Fuursted, K., Gahrn-Hansen, B., Jensen, I. M., Knudsen, J. D., Lundgren, B., Schønheyder, H. C., & Tvede, M. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.9.4434-4440.2005 · Cited by 178
Candidemia in Norway (1991 to 2003): Results from a Nationwide Study
Sandven, P., Bevanger, L., Digranes, A., Haukland, H. H., Mannsåker, T., Gaustad, P., & the Norwegian Yeast Study Group (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.00029-06 · Cited by 173 · cited 1×
“The four main C. albicans strain clades described from all sources in previous studies (Blignaut et al., 2002; Odds et al., 2006; Pujol et al., 2002; Soll & Pujol, 2003) remain the most commonly encountered in candidaemia in our study, and these and others were found across the range of hospitals…”
BackgroundRex, J. H., Nelson, P. W., Paetznick, V. L., Lozano-Chiu, M., Espinel-Ingroff, A., & Anaissie, E. J. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.1.129 · Cited by 167 · cited 2×
“tropicalis, where the MICs reflect a common artefactual trailing growth phenomenon (Arthington-Skaggs et al., 2002; Rex et al., 1998), and three isolates of C.”
BackgroundCuenca-Estrella, M., Moore, C. B., Barchiesi, F., Bille, J., Chryssanthou, E., Denning, D. W., Donnelly, J. P., Dromer, F., Dupont, B., Rex, J. H., et al. (2003) · Clinical Microbiology and Infection · doi:10.1046/j.1469-0691.2003.00592.x · Cited by 160 · cited 1×
“…determination of MIC end points from dose-response curves, is essentially the same as the European Committee on Antimicrobial Susceptibility Testing (EUCAST) antifungal methodology (Cuenca-Estrella et al., 2002b, 2003, 2005) and all MICs were read at 24 h in conformity with EUCAST norms.”
Arthington-Skaggs, B. A., Lee-Yang, W., Ciblak, M. A., Frade, J. P., Brandt, M. E., Hajjeh, R. A., Harrison, L. H., Sofair, A. N., & Warnock, A. D. W. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.8.2477-2481.2002 · Cited by 158 · cited 3×
“Our incidence rate of 4.8 per 100 000 is at the high end of comparable studies from other European countries (Asmundsdottir et al., 2002; Laupland et al., 2005; Poikonen et al., 2003; Sandven et al., 2006) with the exception of Denmark (Arendrup et al., 2005) and lower than has been recorded in…”
BackgroundResultInfluentialMeis, J. F. G. M., Ruhnke, M., De Pauw, B. E., Odds, F. C., Siegert, W., & Verweij, P. E. (1999) · Emerging Infectious Diseases · doi:10.3201/eid0501.990119 · Cited by 153
Self-citationOdds, F. C., Davidson, A. D., Jacobsen, M. D., Tavanti, A., Whyte, J. A., Kibbler, C. C., Ellis, D. H., Maiden, M. C. J., Shaw, D. J., & Gow, N. A. R. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.00934-06 · Cited by 151 · cited 4×
“glabrata isolates by MLST confirmed previous evidence that individual patients usually carry a single strain type of a species in repeated isolates (Odds et al., 2006).”
BackgroundResultInfluentialSelf-citationMultilocus Sequence Typing for Differentiation of Strains of Candida tropicalis
Tavanti, A., Davidson, A. D., Johnson, E. M., Maiden, M. C. J., Shaw, D. J., Gow, N. A. R., & Odds, F. C. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.11.5593-5600.2005 · Cited by 147
Self-citationGlobal trends in candidemia: Review of reports from 1995–2005
Morgan, J. (2005) · Current Infectious Disease Reports · doi:10.1007/s11908-005-0044-7 · Cited by 139
Cuenca-Estrella, M., Lee-Yang, W., Ciblak, M. A., Arthington-Skaggs, B. A., Mellado, E., Warnock, D. W., & Rodriguez-Tudela, J. L. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.11.3644-3647.2002 · Cited by 134 · cited 3×
“Recent surveys of candidaemia from Spain and Italy have shown prevalences of C. parapsilosis between 20 and 40 % (Almirante et al., 2005; Cuenca-Estrella et al., 2002a; Marco et al., 2003; Pemán et al., 2005; San Miguel et al., 2005).”
BackgroundMethodPem�n, J., Cant�n, E., Gobernado, M., & and the Spanish ECMM Working Group on Candidaemia (2004) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-004-1267-5 · Cited by 133
Invasive Candida species infections: a 5 year population-based assessment
Laupland, K. B., Gregson, D. B., Church, D. L., Ross, T., & Elsayed, S. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki258 · Cited by 130
Candidemia in Finland, 1995–1999
Poikonen, E., Lyytikäinen, O., Anttila, V.-J., & Ruutu, P. (2003) · Emerging Infectious Diseases · doi:10.3201/eid0908.030069 · Cited by 121
Pujol, C., Pfaller, M., & Soll, D. R. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.8.2729-2740.2002 · Cited by 93 · cited 2×
“albicans strain clades described from all sources in previous studies (Blignaut et al., 2002; Odds et al., 2006; Pujol et al., 2002; Soll & Pujol, 2003) remain the most commonly encountered in candidaemia in our study, and these and others were found across the range of hospitals submitting isolates.”
BackgroundResultBlignaut, E., Pujol, C., Lockhart, S., Joly, S., & Soll, D. R. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.3.826-836.2002 · Cited by 92 · cited 2×
“albicans strain clades described from all sources in previous studies (Blignaut et al., 2002; Odds et al., 2006; Pujol et al., 2002; Soll & Pujol, 2003) remain the most commonly encountered in candidaemia in our study, and these and others were found across the range of hospitals submitting isolates.”
BackgroundResultMiguel, L. G. S., Cobo, J., Otheo, E., Sánchez-Sousa, A., Abraira, V., & Moreno, S. (2005) · Infection Control & Hospital Epidemiology · doi:10.1086/502582 · Cited by 83 · cited 5×
“Recent surveys of candidaemia from Spain and Italy have shown prevalences of C. parapsilosis between 20 and 40 % (Almirante et al., 2005; Cuenca-Estrella et al., 2002a; Marco et al., 2003; Pemán et al., 2005; San Miguel et al., 2005).”
BackgroundInfluentialAntifungal susceptibility testing of yeasts: evaluation of technical variables for test automation
Odds, F. C., Vranckx, L., & Woestenborghs, F. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.9.2051 · Cited by 81 · cited 3×
“Our method (Odds et al., 1995), and the EUCAST method (Cuenca-Estrella et al.”
MethodSelf-citationSoll, D. R., & Pujol, C. (2003) · FEMS Immunology & Medical Microbiology · doi:10.1016/s0928-8244(03)00242-6 · Cited by 80 · cited 2×
“The four main C. albicans strain clades described from all sources in previous studies (Blignaut et al., 2002; Odds et al., 2006; Pujol et al., 2002; Soll & Pujol, 2003 ) remain the most commonly encountered in candidaemia in our study, and these and others were found across the range of hospitals submitting isolates.”
BackgroundMarco, F., Danés, C., Almela, M., Jurado, A., Mensa, J., de la Bellacasa, J. P., Espasa, M., Martínez, J. A., & de Anta, M. T. J. (2003) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(03)00086-5 · Cited by 71
Cuenca‐Estrella, M., Gómez‐López, A., Mellado, E., & Rodriguez-Tudela, J. L. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01166.x · Cited by 66 · cited 1×
“…determination of MIC end points from dose-response curves, is essentially the same as the European Committee on Antimicrobial Susceptibility Testing (EUCAST) antifungal methodology (Cuenca-Estrella et al., 2002b, 2003, 2005) and all MICs were read at 24 h in conformity with EUCAST norms.”
Candida dubliniensis at a University Hospital in Saudi Arabia
Fotedar, R., & Al‐Hedaithy, S. S. A. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.5.1907-1911.2003 · Cited by 63
Antifungal susceptibilities of Candida spp. isolated from blood in Spain and Argentina, 1996-1999
Cuenca-Estrella, M. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf060 · Cited by 53
Impaired gut function as risk factor for invasive candidiasis in neutropenic patients
Blijlevens, N. M. A., Donnelly, J. P., & De Pauw, B. E. (2002) · British Journal of Haematology · doi:10.1046/j.1365-2141.2002.03394.x · Cited by 41 · cited 3×
“Typical chemotherapeutic interventions in haematological practice also lower the barrier integrity of http://jmm.sgmjournals.org 1071 the gut wall, permitting yeasts to overgrow and enter the bloodstream (Blijlevens et al., 2002).”
BackgroundInfluentialANTIFUNGAL SUSCEPTIBILITIES OF CANDIDA SPP. ISOLATED FROM BLOOD IN SPAIN AND ARGENTINA
Estrella, M. C., & Rodero, L. (2002) · Cited by 23
Andes, D. R. (2004) · Drug Resistance Updates · doi:10.1016/j.drup.2004.06.002 · Cited by 20 · cited 1×
“When an isolate is found to be in the S-DD category, fluconazole dosing should be increased in an effort to achieve the AUC (area under the curve)/MIC ratio of 25 shown to be needed for eradication of infection in experimental pharmacodynamic studies (Andes, 2004; Andes & van Ogtrop, 1999).”
BackgroundVázquez, J. A., & Sobel, J. D. (2003) · doi:10.1093/oso/9780195148091.003.0011 · Cited by 18
FatalCandida dubliniensisSepticemia in a Patient with AIDS
Chan‐Tack, K. M. (2005) · Clinical Infectious Diseases · doi:10.1086/428846 · Cited by 17 · cited 2×
“However, it has been regularly reported as a cause of candidaemia since 1999 (Chan-Tack, 2005; Kibbler et al., 2003; Meis et al., 1999; Tortorano et al., 2004) and one study even identified C. dubliniensis in over 16 % of cases of candidaemia (Fotedar & Al Hedaithy, 2003).”
Background
Research works printed but not linked: 1
- 2004, Candidaemia reports, England, Wales, and Northern Ireland: 2003, CDR Weekly, 14, 1
Cited by
Hidden Killers: Human Fungal Infections
Brown, G. D., Denning, D. W., Gow, N. A. R., Levitz, S. M., Netea, M. G., & White, T. C. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004404 · Cited by 4,284
“The occurrence of disseminated Candida infections has been surveyed frequently in the United States and in many European countries, and variable reported incidences ranging from 2.4 (Norway) to 29 cases (Iowa, United States) per 100,000 inhabitants have been published ( 14 – 23 ).”
InfluentialSelf-citationGlobal and Multi-National Prevalence of Fungal Diseases-Estimate Precision
Bongomin, F., Gago, S., Oladele, R., & Denning, D. (2017) · Journal of Fungi · doi:10.3390/jof3040057 · Cited by 2,953
“8 cases per 100,000 population per year shortly after the millennium, 254 bloodstream and 669 invasive Candida cases annually [27].”
BackgroundChanges in the epidemiological landscape of invasive candidiasis
Lamoth, F., Lockhart, S. R., Berkow, E. L., & Calandra, T. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx444 · Cited by 547
Changing epidemiology of systemic fungal infections
Richardson, M., & Lass-Flörl, C. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2008.01978.x · Cited by 524
“Of note is the emergence of Candida dubliniensis in some centres [107].”
BackgroundAntifungal drug resistance among Candida species: mechanisms and clinical impact
Sanguinetti, M., Posteraro, B., & Lass‐Flörl, C. (2015) · Mycoses · doi:10.1111/myc.12330 · Cited by 394
Metadata
- Authors
- Odds, F. C., Hanson, M. F., Davidson, A. D., Jacobsen, M. D., Wright, P., Whyte, J. A., Gow, N. A. R., & Jones, B. L.
- Affiliations
- University of Aberdeen (GB)
- Western General Hospital (GB)
- Glasgow Royal Infirmary (GB)
- Venue
- Journal of Medical Microbiology
- Publisher
- Microbiology Society
- Published
- 2007-08-01
- Volume
- 56
- Issue
- 8
- Pages
- 1066-1075
- ISSN
- 0022-2615 (ISSN-L)
- 1473-5644
- PMC
- PMC2884937
- OpenAlex
- W2165403985
- Semantic Scholar
- 9ce27f081fa0bd39c9dc33b36b53081b5f8a01f9
- Cited by
- 176
- References
- 58
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 3 · 2023: 1 · 2022: 4 · 2021: 6 · 2020: 3 · 2019: 10 · 2018: 4 · 2017: 11 · 2016: 9 · 2015: 16 · 2014: 12 · 2013: 11 · 2012: 24
- FWCI
- 8.46
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- cc-by
- Locations
- Journal of Medical Microbiology (publishedVersion)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust (74898)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Immunology and Microbiology › Microbiology › Yeasts and Rust Fungi Studies
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Keywords
- candidemia, bloodstream infection, invasive candidiasis, Candida albicans, Candida glabrata, Candida parapsilosis, Candida dubliniensis, Candida tropicalis, Candida lusitaniae, fluconazole resistance, antifungal susceptibility, multilocus sequence typing, intensive care unit, abdominal diseases, laparotomy, incidence, Scotland
- MeSH terms
- Adolescent, Adult, Aged, Antifungal Agents, Bacterial Infections, Candida, Candidiasis, Catheters, Indwelling, Child, Child, Preschool, Female, Health Surveys, Humans, Infant, Laparotomy, Male, Microbial Sensitivity Tests, Middle Aged, Prospective Studies, Risk Factors, Scotland, Fluconazole, Incidence, Fungemia, Mycological Typing Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.